Which transporter is involved in multidrug resistance (MDR)?
Multidrug resistance in oncology frequently originates from increased efflux reducing intracellular drug accumulation below cytotoxic threshold. ATP-binding cassette transporters, particularly ABCB1 P-glycoprotein, ABCC1 MRP1 and ABCG2 BCRP, are major contributors. They are primary active pumps using two ATP hydrolysis events per cycle to switch transmembrane domains from high-affinity inward-facing to low-affinity outward-facing state, literally vacuuming hydrophobic substrates from inner membrane leaflet. Their drug-binding pocket is large, flexible and polyspecific, accommodating anthracycl
Ref: Gottesman et al., Nat Rev Cancer 2002, Multidrug resistance; Ambudkar et al., Annu Rev Pharmacol 1999.